Inactive Instrument

News AlzChem Group AG Deutsche Boerse AG

Equities

DE000A0AHT46

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

AlzChem : Information pursuant to Section 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212	Mar. 21	PU
Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding	Mar. 15	EQ
German arms industry receives EU millions for projects	Mar. 15	DP
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments	Mar. 11	EQ
Transcript : AlzChem Group AG, 2023 Earnings Call, Mar 01, 2024	Mar. 01
Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success	Mar. 01	EQ
AlzChem Group AG Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
AlzChem Group AG Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
AFR: Alzchem Group AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	Feb. 21	EQ
Alzchem Group AG: Long-Covid: New clinical studies show high efficacy of creatine supplementation	Jan. 11	EQ
AlzChem : Happy New Year 2024	Jan. 02	PU
Alzchem Group AG awarded for sustainable supply chains: Outstanding result certified by 'Together for Sustainability (TfS)' initiative	Dec. 13	EQ
Germany’s Alzchem Group Names New CFO	Dec. 08	MT
Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024	Dec. 08	EQ
Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024	Dec. 08	PU
AlzChem Group AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-27	CI
Alzchem Group AG significantly increases EBITDA by 19.8% to EUR 56.3 million in the nine-month period 2023	23-10-26	EQ
Alzchem Group AG raises EBITDA forecast into the range of EUR 80 million for fiscal year 2023 despite slightly lower sales expectation	23-10-18	EQ
Alzchem Group AG: Creatine product 'Creavitalis': Wholesome taste and positive benefits for vegetarian and vegan foods	23-09-14	EQ
Transcript : AlzChem Group AG, H1 2023 Earnings Call, Aug 03, 2023	23-08-03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News AlzChem Group AG Deutsche Boerse AG

Equities

DE000A0AHT46

Summary

Filters